论文部分内容阅读
目的:比较单用阿奇霉素与阿奇霉素联合小儿清肺颗粒治疗小儿支原体肺炎的临床疗效。方法:选取小儿支原体肺炎患者110例,将其随机分为观察组与对照组,观察组55例采用阿奇霉素联合小儿清肺颗粒,对照组55例仅使用阿奇霉素治疗,观察比较两组治疗效果、不良反应等情况。结果:观察组总有效率为96.4%,明显高于对照组的83.6%,差异具有统计学意义(P<0.05);观察组不良反应发生率为7.3%,显著低于对照组的21.8%(P<0.05)。结论:阿奇霉素联合小儿清肺颗粒治疗小儿支原体肺炎效果优于单独使用阿奇霉素,并发症发生率更低,有助于患儿肺功能的恢复,值得临床推广应用。
Objective: To compare the clinical effects of azithromycin and azithromycin combined with Xiaoer Qingfei Granule in treating children with mycoplasma pneumonia. Methods: 110 cases of children with mycoplasma pneumonia were selected and randomly divided into observation group and control group. In the observation group, 55 cases were treated with azithromycin and Xiaoer Qingfei granule. In the control group, 55 cases were treated with azithromycin only. The therapeutic effects and the adverse effects in both groups were observed and compared Reaction and so on. Results: The total effective rate in the observation group was 96.4%, which was significantly higher than 83.6% in the control group (P <0.05). The adverse reaction rate in the observation group was 7.3%, which was significantly lower than that in the control group (21.8% P <0.05). Conclusion: Azithromycin combined with Xiaoer Qingfei Granules in children with mycoplasma pneumonia is superior to azithromycin alone, the complication rate is lower, which is helpful to the recovery of pulmonary function in children. It is worthy of clinical application.